However, further analyses of the patient samples revealed that CD109 expression significantly associated with increasingly phosphorylated STAT3 (p-STAT3, Tyr705) (P = 0.004) and higher number of Ki-67–positive, proliferating tumor cells (P = 0.027) (Supplemental Table 2). This evidence concerns the gene CD109 and neoplasm.